Novo Nordisk Inc. V. Mylan Pharmaceuticals Inc. - 1:24-cv-01013

Novo Nordisk Inc. V. Mylan Pharmaceuticals Inc. (Case No. 1:24-cv-01013), filed on Sep 5, 2024 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:24-cv-01013
Filing Date
Sep 5, 2024
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Novo Nordisk A/S -
Mylan Pharmaceuticals Inc. -

Patents Involved

There is a single patent involved in this case.

Application NumberPatent Number
-US12029779B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Sep 6, 2024Remark: MDL Panel has been notified. (mws)PACER Document
Sep 11, 2024WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For Mylan Pharmaceuticals Inc. waiver sent on 9/10/2024, answer due 11/12/2024. (Murray, Travis) (Entered: 09/11/2024)PACER Document
Sep 11, 2024STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 09/11/2024)PACER Document
Nov 6, 2024NOTICE OF SERVICE of (1) Defendants Initial Invalidity Contentions Regarding U.S. Patent No. 12,029,779 and (2) Defendants Initial Non-Infringement Contentions Regarding U.S. Patent No. 12,029,779 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 11/06/2024)PACER Document
Nov 12, 2024Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Viatris Inc. for Mylan Pharmaceuticals Inc. filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 11/12/2024)PACER Document
Nov 12, 2024ANSWER to 1 Complaint, COUNTERCLAIM against All Plaintiffs by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 11/12/2024)PACER Document
Nov 22, 2024[SEALED] Letter to The Honorable Colm F. Connolly from Travis J. Murray regarding proposed schedules - re (12 in 1:24-cv-01013-CFC, 227 in 1:23-cv-00101-CFC) Joint MOTION and [Proposed] Order to Consolidate Case No. 24-1013-CFC into Lead Case No. 23-101-CFC . (Attachments: # 1 Exhibit A)(Murray, Travis) (Entered: 11/22/2024)PACER Document
Nov 22, 2024Joint MOTION and [Proposed] Order to Consolidate Case No. 24-1013-CFC into Lead Case No. 23-101-CFC - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Murray, Travis) (Entered: 11/22/2024)PACER Document
Nov 26, 2024REDACTED VERSION of (228 in 1:23-cv-00101-CFC, 13 in 1:24-cv-01013-CFC) Letter, by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # 1 Ex. A)(Murray, Travis) (Entered: 11/26/2024)PACER Document
Dec 3, 2024ANSWER to 10 Answer to Complaint, Counterclaim by Novo Nordisk Inc., Novo Nordisk A/S.(Murray, Travis) (Entered: 12/03/2024)PACER Document
Dec 6, 2024ORDER granting (227 in 23-101, 12 in 24-1013) Joint MOTION and [Proposed] Order to Consolidate Case No. 24-1013-CFC into Lead Case No. 23-101-CFC. These actions are consolidated for all purposes, and all papers shall be filed in C.A. No. 23-101-CFC. The Protective Order (C.A. No. 23-101-CFC, D.I. 40) and ESI Order (C.A. No. 23-101-CFC, D.I. 43) shall govern. The Scheduling Order shall be modified by the Proposed Consolidated Case Schedule and shall govern. Signed by Judge Colm F. Connolly on 12/6/2024. Associated Cases: 1:23-cv-00101-CFC, 1:24-cv-01013-CFC (mws) Modified on 12/6/2024 (mws). (Entered: 12/06/2024)PACER Document
Nov 26, 2024REDACTED VERSION of (228 in 1:23-cv-00101-CFC, 13 in 1:24-cv-01013-CFC) Letter, by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # 1 Ex. A)(Murray, Travis) (Entered: 11/26/2024)Attachment
Sep 11, 2024Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:24-cv-01013-CFC, 1:24-cv-01014-CFC (rjb)PACER Document
Dec 3, 2024ORAL ORDER Setting Hearings: re (228 in 1:23-cv-00101-CFC, 13 in 1:24-cv-01013-CFC) Letter, (A Scheduling Teleconference is set for 12/6/2024 at 09:00 AM Telephonically before Judge Colm F. Connolly). Counsel for Plaintiffs to coordinate the call and email the dial-in information to chambers. Ordered by Judge Colm F. Connolly on 12/3/2024. Associated Cases: 1:23-cv-00101-CFC, 1:24-cv-01013-CFC(mws)PACER Document
Dec 6, 2024Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 12/6/2024. (Court Reporter Bonnie Archer.) Associated Cases: 1:23-cv-00101-CFC, 1:24-cv-01013-CFC(mws)PACER Document
Dec 6, 2024Case associated with lead case: Create association to 1:23-cv-00101-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 23-101-CFC ONLY. (mws)PACER Document